Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IVA
- Price
- 3.29
- Stock movement down
- -0.32 (-6.99%)
- Company name
- Inventiva Sa
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 592.40M
- Ent value
- -
- Price/Sales
- 15.37
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 8.27%
- 1 year return
- 82.05%
- 3 year return
- -5.82%
- 5 year return
- -18.57%
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
IVA does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 15.37 |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 139.06M |
| EPS (TTM) | -4.01 |
| FCF per share (TTM) | -0.71 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 38.55M |
| Gross profit (TTM) | 37.43M |
| Operating income (TTM) | -199.91M |
| Net income (TTM) | -208.37M |
| EPS (TTM) | -4.01 |
| EPS (1y forward) | -1.13 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 97.11% |
| Operating margin (TTM) | -518.58% |
| Profit margin (TTM) | -540.52% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 0.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -72.76M |
| Capital expenditures (TTM) | 620.00K |
| Free cash flow (TTM) | -36.69M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.59 |
| Daily high | 4.70 |
| Daily low | 4.11 |
| Daily Volume | 39K |
| All-time high | 19.00 |
| 1y analyst estimate | 10.90 |
| Beta | 0.62 |
| EPS (TTM) | -4.01 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 25 Sep 2025 |
Downside potential
Loading...
Downside potential data
| IVA | S&P500 | |
| Current price drop from All-time high | -77.58% | -1.46% |
| Highest price drop | -91.32% | -56.47% |
| Date of highest drop | 9 Oct 2024 | 9 Mar 2009 |
| Avg drop from high | -59.28% | -10.99% |
| Avg time to new high | 51 days | 12 days |
| Max time to new high | 1153 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
592.40M
Marketcap category
Small-cap
Description
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.
Employees
114
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page